510(k) Report

510(k) · Cleared

Cleared

1ML Unitract 27G X 1/2 Tuberculin Syringe, Model 132BY2-1

K100998510(k) TraditionalCleared Aug 30, 2010140-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Unilife Medical Solutions Limited · MEG Syringe, Antistick

Cleared on Aug 30, 2010 as substantially equivalent to K093400 (Unilife Medical Solutions Limited, 2010) and 1 other predicate after a 140-day review. Its family tree reaches back 4 generations to 1998.

Decided
Aug 30, 2010
Review
140 days
Class
Class II
Product code
MEG
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K980069 (1998). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK980069 Vanishpoint SyringeRetractable Technologies, Inc. · 1998
  2. 3 generations backK023752 BD Integra SyringeBd · 2003 · Recalled
  3. 2 generations backK080877 1ML Unitract Insulin Syringe 27G*1/2 , 1ML Unitract Syringe 29G*1/2Unilife Medical Solutions Limited · 2008
  4. 1 generation backK093400 1ML Unitract Insulin Syringe 27G X 1/2 and 29G X 1/2Unilife Medical Solutions Limited · 2010
  5. This deviceK100998 1ML Unitract 27G X 1/2 Tuberculin Syringe, Model 132BY2-1Unilife Medical Solutions Limited · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K980069Vanishpoint SyringeRetractable Technologies, Inc.1998—
−3K023752BD Integra SyringeBd20032
−2K0808771ML Unitract Insulin Syringe 27G*1/2 , 1ML Unitract Syringe 29G*1/2Unilife Medical Solutions Limited2008—
−1K0934001ML Unitract Insulin Syringe 27G X 1/2 and 29G X 1/2Unilife Medical Solutions Limited2010—
0 (this device)K1009981ML Unitract 27G X 1/2 Tuberculin Syringe, Model 132BY2-1Unilife Medical Solutions Limited2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200110
200210
200510
FIG. 1 — Lineage of K100998, 1998–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MEG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MEG device

  1. #1 K192551 1ml Luer Slip or Luer Lock Syringe, Syringe…score 19.6 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K0934001ML Unitract Insulin Syringe 27G X 1/2 and 29G X 1/2
Summary page 1
…on Name: Piston Syringe Classification: Syringe, Piston; 2! CFR 880.5860; FMF; Class 11 Predicate Devices: Unitract Insulin Syringe (K093400); BD Integra Syringe (K023752) Device Description: The IlmL Unitract® Tuberculin Syringe is…
Unilife Medical Solutions Limited2010—
*K023752BD Integra Syringe
Summary page 1
…Syringe, Piston; 2! CFR 880.5860; FMF; Class 11 Predicate Devices: Unitract Insulin Syringe (K093400); BD Integra Syringe (K023752) Device Description: The IlmL Unitract® Tuberculin Syringe is a sterile, fixed needle, singl…
Bd20032

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 5.0 years on median.
  • 1 of the 8 ancestors has a recall of any class.

How does its category compare?

All MEG devices

MEG Syringe, Antistick: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · MEG

1in 2025

2007: 82008: 42009: 22010: 22011: 52012: 52013: 12014: 52015: 72016: 32017: 32018: 12019: 42020: 42021: 52022: 132023: 52025: 12026 (partial year): 1
2007high 13 (2022) · low 0 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MEG

229in 2023

2007: 100 days median2008: 145 days median2011: 113 days median2012: 109 days median2014: 153 days median2015: 253 days median2016: 179 days median2017: 130 days median2019: 249 days median2020: 296 days median2021: 152 days median2022: 216 days median2023: 229 days median
2007high 296 (2020) · low 100 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MEG

1in 2024

2008: 12010: 12013: 52015: 12024: 1, 1 Class I
2007high 5 (2013) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · MEG

148in 2025

2007: 212008: 202009: 262010: 342011: 342012: 222013: 272014: 362015: 512016: 942017: 1812018: 2692019: 4972020: 3532021: 5412022: 1702023: 1202024: 1122025: 148
2007high 541 (2021) · low 20 (2008)2025

MAUDE reports naming product code MEG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078100021
20084145120
20092—026
20102—134
20115113034
20125109022
20131—527
20145153036
20157253151
20163179094
201731300181
20181—0269
201942490497
202042960353
202151520541
2022132160170
202352290120
20240—1 (1)112
20251—0148
20261—0—

What is it indicated for?

The Unitract Tuberculin Syringe, as supplied, is a device with a small barrel, plunger, and fixed needle, calibrated in milliliters (0.01 increments) to be used to administer (infuse) medication subcutaneous, intramuscular, or intradermal. It incorporates features that include reuse prevention (auto-disable) and sharps injury prevention (automatic needle retraction).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K100998: 1ML Unitract 27G X 1/2 Tuberculin Syringe, Model 132BY2-1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K100998

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026